GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript - Thomson StreetEvents

GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript

GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript - Thomson StreetEvents
GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript
Published Sep 28, 2023
19 pages (12978 words) — Published Sep 28, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of GSK.L conference call or presentation 28-Sep-23 1:00pm GMT

  
Brief Excerpt:

...Good afternoon, everyone, who's based in the U.K., and good morning to all of those in the U.S. at the start of your day. My name is David Redfern, I'm President of Corporate Development for GSK and the Chairman of ViiV Healthcare. I'm delighted to host this Meet the Management event focused on our HIV business for analysts and investors. As usual, the materials presented today are available on gsk.com. You should see in the front of you now the title slide of this presentation, getting ahead of HIV together. I should just say that we are now in the close period, and therefore, we will not be making any comments today on performance matters relating to the current quarter. Those will be covered in the GSK Q3 results reported shortly. I would just refer you to Slide 2, which contains our cautionary and forward-looking statements. Moving on to Slide 3, which is a summary of what we should cover today. I'm delighted to be joined by Deborah Waterhouse, the CEO of ViiV Healthcare and President...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
GSK plc
Ticker
GSK.L
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : My question is on the guidance. Today, you've upgraded that 2021-2026 outlook. The footnote there states that you included an estimated GBP 200 million of annual impact on 2025 related to IRA. I just wondering if you can walk us through how you get to that figure what your assumptions are behind that GBP 200 million headwind in 2025?

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Another more financial question for me. Just thinking about the various combinations, novel molecules you've got coming through. And you talked any potential (inaudible), you need to consider when we're thinking about modeling these assets in the longer term. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. SEPTEMBER 28, 2023 / 1:00PM, GSK.L - GSK plc Getting ahead of HIV with ViiV Management Presentation

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Can you quantify the level of those payaways on the bNAb (inaudible).

Table Of Contents

GSK plc Q4 2024 Earnings Call Transcript – 2025-02-05 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 5-Feb-25 10:45am GMT

GSK plc at JPMorgan Healthcare Conference Transcript – 2025-01-14 – US$ 54.00 – Edited Transcript of GSK.L presentation 14-Jan-25 3:30pm GMT

GSK plc Q3 2024 Earnings Call Transcript – 2024-10-30 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 30-Oct-24 12:00pm GMT

GSK plc at Bank of America Global Healthcare Conference Transcript – 2024-09-19 – US$ 54.00 – Edited Transcript of GSK.L presentation 19-Sep-24 8:05am GMT

GSK plc Q3 2023 Earnings Call Transcript – 2023-11-01 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 1-Nov-23 12:00pm GMT

GSK plc at Bank of America Merrill Lynch Global Healthcare Conference Transcript – 2023-09-14 – US$ 54.00 – Edited Transcript of GSK.L presentation 14-Sep-23 8:05am GMT

GSK plc at Citi BioPharma Conference Transcript – 2023-09-07 – US$ 54.00 – Edited Transcript of GSK.L presentation 7-Sep-23 12:50pm GMT

GSK plc Q2 2023 Earnings Call Transcript – 2023-07-26 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 26-Jul-23 11:00am GMT

GSK plc Virtual Management Event: Getting Ahead of Infectious Disease Transcript – 2023-06-27 – US$ 54.00 – Edited Transcript of GSK.L conference call or presentation 27-Jun-23 1:00pm GMT

GSK plc at Goldman Sachs Healthcare Conference Transcript – 2023-06-13 – US$ 54.00 – Edited Transcript of GSK.L presentation 13-Jun-23 4:20pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript" Sep 28, 2023. Alacra Store. May 01, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/GSK-plc-Getting-ahead-of-HIV-with-ViiV-Management-Presentation-T15736308>
  
APA:
Thomson StreetEvents. (2023). GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript Sep 28, 2023. New York, NY: Alacra Store. Retrieved May 01, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/GSK-plc-Getting-ahead-of-HIV-with-ViiV-Management-Presentation-T15736308>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.